• Loading stock data…

Tachyon Presents New Data Supporting the Development of TACH101, a Novel KDM4 Inhibitor, as a Potential Therapy for Gastrointestinal Cancers at the 2022 ASCO-GI Conference

[#item_full_content]

Print Friendly, PDF & Email
Spread the word